NCT02679781View on ClinicalTrials.gov

Nasal Versus Oral Midazolam Sedation in Routine Pediatric Dental Care

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

March 28, 2017

Primary Completion Date

December 15, 2020

Study Completion Date

December 15, 2020

Conditions
Conscious Sedation
Interventions
DRUG

oral midazolam

administration of 0.5mg/kg oral midazolam. During dental treatment 50% nitrous oxide/ 50% oxygen will be administered via nasal hood.

DRUG

nasal midazolam

administration of 0.2mg/kg nasal midazolam. During dental treatment 50% nitrous oxide/ 50% oxygen will be administered via nasal hood.

Trial Locations (1)

91120

Hadassah Medical Organization, Jerusalem

All Listed Sponsors
lead

Hadassah Medical Organization

OTHER

NCT02679781 - Nasal Versus Oral Midazolam Sedation in Routine Pediatric Dental Care | Biotech Hunter | Biotech Hunter